USANA Health Sciences, Inc. Investor Relations

Financial Information

Fiscal Year Ended Jan 3, 2026

Latest Financial Results

FY 2025

Get Alerts

$925M

Fiscal year 2025 net sales were $925 million

$0.58

Fiscal year 2025 diluted EPS totaled $0.58

For complete information regarding our financials, see our periodic filings

View the Latest Financials

Balance

Includes Current Assets, Liabilities and Stockholder's Equity

View Balance Sheet

Income

Includes Total Net Sales, Cost & Expenses and Earnings per share

View Income Statement

Cash

Includes Net Income, Adjustments, and Cash flows from investing & financing activities

View Cash Flow